{"Q27286421": {"ikey": "WXNRAKRZUCLRBP-UHFFFAOYSA-N", "reframe_id": "", "qid": "", "alt_id": "", "gvk": {"hvac_id": "CBR-HVAC-02492", "gvk_id": 16001459, "drug_name": "AVRIDINE", "phase": ["PRESCRIPTION DRUG"], "category": ["Antiviral"], "smiles": "[H]OCCN(CCO[H])CCCN(CCCCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCCCC", "synonyms": ["Avridinum", "BRN-2227682", "CP-20961"], "ikey": "WXNRAKRZUCLRBP-UHFFFAOYSA-N"}, "integrity": {"phase": ["Preclinical"], "drug_name": "Auridine", "PubChem CID": "CID37186", "smiles": "CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)CCCN(CCO)CCO", "ikey": "WXNRAKRZUCLRBP-UHFFFAOYSA-N", "id": 90012, "category": ["Immunomodulators", "Antiviral Drugs"], "wikidata": "Q27286421"}, "informa": {"phase": ["No Development Reported"], "drug_name": ["avridine", "CP-20961"], "highest_phase": "Phase I Clinical Trial", "target_name": ["Unspecified"], "smiles": "CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)CCCN(CCO)CCO", "origin": "Chemical, synthetic", "ikey": "WXNRAKRZUCLRBP-UHFFFAOYSA-N", "chemical_name": "Ethanol, 2,2'-[[3-(dioctadecylamino)propyl]imino]bis- [CAS]", "informa_id": "informa_00391", "target_families": ["", "Receptor > Cytokine receptor > Class II"], "PubChem CID": "CID37186", "mechanism": ["Interferon receptor agonist"], "wikidata": "Q27286421"}, "assay": []}, "Q27088554": {"ikey": "NNBGCSGCRSCFEA-UHFFFAOYSA-N", "reframe_id": "", "qid": "", "alt_id": "", "gvk": {"hvac_id": "CBR-HVAC-00627", "gvk_id": 5917165, "drug_name": "RILAPLADIB", "phase": ["Phase II"], "roa": ["Oral"], "category": ["Antiarteriosclerotic"], "mechanism": ["Phospholipase A2 Inhibitor"], "smiles": "COCCN1CCC(CC1)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C(=O)CN4C(SCC5=C(F)C(F)=CC=C5)=CC(=O)C6=C4C=CC=C6", "synonyms": ["659032", "SB-659032"], "ikey": "NNBGCSGCRSCFEA-UHFFFAOYSA-N"}, "integrity": {"phase": ["Phase II"], "drug_name": "Rilapladib", "PubChem CID": "CID9918381", "smiles": "COCCN1CCC(CC1)N(Cc2ccc(cc2)c3ccc(cc3)C(F)(F)F)C(=O)Cn4c5ccccc5c(=O)cc4SCc6cccc(c6F)F", "ikey": "NNBGCSGCRSCFEA-UHFFFAOYSA-N", "id": 320250, "category": ["Alzheimer's Dementia, Treatment of ", "Atherosclerosis Therapy"], "mechanism": ["Lipoprotein Associated Phospholipase A2 (Lp-PLA2) Inhibitors", "Signal Transduction Modulators"], "wikidata": "Q27088554"}, "informa": {"phase": ["Phase II"], "drug_name": ["rilapladib", "659032", "GSK-659032", "GSK659032", "SB-659032", "SB659032"], "PubChem CID": "CID9918381", "target_name": ["phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)"], "smiles": "COCCN1CCC(CC1)N(Cc1ccc(cc1)-c1ccc(cc1)C(F)(F)F)C(=O)Cn1c(SCc2cccc(F)c2F)cc(=O)c2ccccc12", "origin": "Chemical, synthetic", "ikey": "NNBGCSGCRSCFEA-UHFFFAOYSA-N", "chemical_name": "1(4H)-quinolineacetamide, 2-[[(2,3-difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]", "informa_id": "informa_05357", "mechanism": ["Phospholipase A2 inhibitor"], "target_families": ["Enzyme > Lipase", ""], "wikidata": "Q27088554"}, "assay": [{"ac50": 2.22e-06, "PubChem CID": "CID9918381", "pubchem_label": "Rilapladib", "assay_title": "Crypto-C. parvum HCI proliferation assay - Sterling Lab", "reframe_id": "RFM-009-515-8", "activity_type": "IC50", "ikey": "NNBGCSGCRSCFEA-UHFFFAOYSA-N", "assay_id": "A00093", "chem_vendor_id": "SP-0017516-017", "wikidata": "Q27088554", "chem_vendor": "Chempartner"}, {"ac50": 1.86e-06, "PubChem CID": "CID9918381", "pubchem_label": "Rilapladib", "assay_title": "Crypto-C. parvum HCI proliferation assay - Bunch Grass Farm", "reframe_id": "RFM-009-515-8", "activity_type": "IC50", "ikey": "NNBGCSGCRSCFEA-UHFFFAOYSA-N", "assay_id": "A00208", "chem_vendor_id": "SP-0017516-017", "wikidata": "Q27088554", "chem_vendor": "Chempartner"}, {"ac50": 5.11e-06, "PubChem CID": "CID9918381", "pubchem_label": "Rilapladib", "assay_title": "Crypto-HCT-8 Host Cells - Sterling Lab C. parvum", "reframe_id": "RFM-009-515-8", "activity_type": "IC50", "ikey": "NNBGCSGCRSCFEA-UHFFFAOYSA-N", "assay_id": "A00209", "chem_vendor_id": "SP-0017516-017", "wikidata": "Q27088554", "chem_vendor": "Chempartner"}, {"ac50": 5.81e-06, "PubChem CID": "CID9918381", "pubchem_label": "Rilapladib", "assay_title": "Crypto-HCT-8 Host Cells - Bunch Grass Farm C. parvum", "reframe_id": "RFM-009-515-8", "activity_type": "IC50", "ikey": "NNBGCSGCRSCFEA-UHFFFAOYSA-N", "assay_id": "A00210", "chem_vendor_id": "SP-0017516-017", "wikidata": "Q27088554", "chem_vendor": "Chempartner"}, {"ac50": 3.26e-06, "PubChem CID": "CID9918381", "pubchem_label": "Rilapladib", "assay_title": "HEK293T 72-h cytotoxicity assay", "reframe_id": "RFM-009-515-8", "activity_type": "IC50", "ikey": "NNBGCSGCRSCFEA-UHFFFAOYSA-N", "assay_id": "A00148", "chem_vendor_id": "SP-0017516-017", "wikidata": "Q27088554", "chem_vendor": "Chempartner"}, {"ac50": 3.47e-06, "PubChem CID": "CID9918381", "pubchem_label": "Rilapladib", "assay_title": "HEK293T Cytotoxicity 72H Assay", "reframe_id": "RFM-009-515-8", "activity_type": "IC50", "ikey": "NNBGCSGCRSCFEA-UHFFFAOYSA-N", "assay_id": "A00251", "chem_vendor_id": "SP-0017516-017", "wikidata": "Q27088554", "chem_vendor": "Chempartner"}]}, "Q27291538": {"ikey": "MPMZSZMDCRPSRF-UHFFFAOYSA-N", "reframe_id": "", "qid": "", "alt_id": "", "gvk": {"hvac_id": "CBR-HVAC-03929", "gvk_id": 5916750, "drug_name": "RO 244736", "phase": ["Clinical"], "roa": ["Oral"], "category": ["Antiinflammatory"], "mechanism": ["Platelet activating factor receptor Antagonist"], "smiles": "CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(SC(=C4)C#CCN5C(=O)C6=CC=CC=C6C7=C5C=CC=C7)N12", "synonyms": ["RO-244736"], "ikey": "MPMZSZMDCRPSRF-UHFFFAOYSA-N"}, "integrity": {"phase": ["Phase II"], "drug_name": "Ro-24-4736", "PubChem CID": "CID60775", "smiles": "Cc1nnc2n1-c3c(cc(s3)C#CCn4c5ccccc5c6ccccc6c4=O)C(=NC2)c7ccccc7Cl", "ikey": "MPMZSZMDCRPSRF-UHFFFAOYSA-N", "id": 155747, "mechanism": ["Platelet-Activating Factor Receptor (PAFR) Antagonists", "Signal Transduction Modulators"]}, "informa": {"phase": ["No Development Reported"], "drug_name": ["Ro-24-4736"], "highest_phase": "Preclinical", "PubChem CID": "CID60775", "target_name": ["platelet-activating factor receptor"], "smiles": "Cc1nnc2CN=C(c3cc(sc3-n12)C#CCn1c2ccccc2c2ccccc2c1=O)c1ccccc1Cl |c:6|", "origin": "Chemical, synthetic", "ikey": "MPMZSZMDCRPSRF-UHFFFAOYSA-N", "chemical_name": "6(5H)-Phenanthridinone, 5-[3-[4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-2-propynyl]-  [CAS]", "informa_id": "informa_03533", "mechanism": ["Platelet activating factor antagonist"], "target_families": ["Receptor > GPCR", ""]}, "assay": [{"ac50": 7.77e-07, "PubChem CID": "CID60775", "pubchem_label": "Ro-24-4736", "assay_title": "Crypto-C. parvum HCI proliferation assay - Sterling Lab", "reframe_id": "RFM-009-875-9", "activity_type": "IC50", "ikey": "MPMZSZMDCRPSRF-UHFFFAOYSA-N", "assay_id": "A00093", "chem_vendor_id": "CBR-HVAC-03929", "chem_vendor": "WuXi"}, {"ac50": 7.540000000000002e-07, "PubChem CID": "CID60775", "pubchem_label": "Ro-24-4736", "assay_title": "Crypto-C. parvum HCI proliferation assay - Bunch Grass Farm", "reframe_id": "RFM-009-875-9", "activity_type": "IC50", "ikey": "MPMZSZMDCRPSRF-UHFFFAOYSA-N", "assay_id": "A00208", "chem_vendor_id": "CBR-HVAC-03929", "chem_vendor": "WuXi"}]}, "Q27077191": {"ikey": "ONPGOSVDVDPBCY-CQSZACIVSA-N", "gvk": {}, "integrity": {"id": 738343, "smiles": "C[C@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(nnc2N)C(=O)Nc3ccc(cc3)C(=O)N4CCN(CC4)C", "drug_name": "X-376", "phase": ["Preclinical"], "category": ["Oncolytic Drugs"], "mechanism": ["ALK Tyrosine Kinase Receptor Inhibitors", "Signal Transduction Modulators"], "ikey": "ONPGOSVDVDPBCY-CQSZACIVSA-N", "wikidata": "Q27077191", "PubChem CID": "CID56960447"}, "informa": {}, "assay": [{"ac50": 1.68e-06, "PubChem CID": "CID56960447", "pubchem_label": "X-376", "assay_title": "Crypto-C. parvum HCI proliferation assay - Sterling Lab", "reframe_id": "RFM-010-991-1", "activity_type": "IC50", "ikey": "ONPGOSVDVDPBCY-CQSZACIVSA-N", "assay_id": "A00093", "chem_vendor_id": "CBR-HVAC-14041", "wikidata": "Q27077191", "chem_vendor": "WuXi"}, {"ac50": 2.02e-06, "PubChem CID": "CID56960447", "pubchem_label": "X-376", "assay_title": "Crypto-C. parvum HCI proliferation assay - Bunch Grass Farm", "reframe_id": "RFM-010-991-1", "activity_type": "IC50", "ikey": "ONPGOSVDVDPBCY-CQSZACIVSA-N", "assay_id": "A00208", "chem_vendor_id": "CBR-HVAC-14041", "wikidata": "Q27077191", "chem_vendor": "WuXi"}, {"ac50": 4.33e-06, "PubChem CID": "CID56960447", "pubchem_label": "X-376", "assay_title": "Crypto-HCT-8 Host Cells - Sterling Lab C. parvum", "reframe_id": "RFM-010-991-1", "activity_type": "IC50", "ikey": "ONPGOSVDVDPBCY-CQSZACIVSA-N", "assay_id": "A00209", "chem_vendor_id": "CBR-HVAC-14041", "wikidata": "Q27077191", "chem_vendor": "WuXi"}, {"ac50": 4.45e-06, "PubChem CID": "CID56960447", "pubchem_label": "X-376", "assay_title": "Crypto-HCT-8 Host Cells - Bunch Grass Farm C. parvum", "reframe_id": "RFM-010-991-1", "activity_type": "IC50", "ikey": "ONPGOSVDVDPBCY-CQSZACIVSA-N", "assay_id": "A00210", "chem_vendor_id": "CBR-HVAC-14041", "wikidata": "Q27077191", "chem_vendor": "WuXi"}, {"ac50": 3.92e-06, "PubChem CID": "CID56960447", "pubchem_label": "X-376", "assay_title": "HEK293T 72-h cytotoxicity assay", "reframe_id": "RFM-010-991-1", "activity_type": "IC50", "ikey": "ONPGOSVDVDPBCY-CQSZACIVSA-N", "assay_id": "A00148", "chem_vendor_id": "CBR-HVAC-14041", "wikidata": "Q27077191", "chem_vendor": "WuXi"}]}, "Q15411004": {"ikey": "WXJFKKQWPMNTIM-VWLOTQADSA-N", "reframe_id": "", "qid": "", "alt_id": "", "gvk": {"hvac_id": "CBR-HVAC-00831", "gvk_id": 17500468, "drug_name": "CMX-001", "phase": ["Phase III"], "roa": ["Oral"], "category": ["Antiviral"], "mechanism": ["Antiviral"], "smiles": "[H]OC[C@H](CN1C=CC(=NC1=O)N([H])[H])OCP(=O)(O[H])OCCCOCCCCCCCCCCCCCCCC", "synonyms": ["CMX-001"], "ikey": "WXJFKKQWPMNTIM-VWLOTQADSA-N"}, "integrity": {"phase": ["Phase III"], "drug_name": "Brincidofovir", "PubChem CID": "CID483477", "smiles": "CCCCCCCCCCCCCCCCOCCCOP(=O)(CO[C@@H](Cn1ccc(nc1=O)N)CO)O", "ikey": "WXJFKKQWPMNTIM-VWLOTQADSA-N", "id": 317302, "category": ["Anti-Herpes Virus Drugs", "Anti-Herpes Simplex Virus Drugs", "Antiviral Drugs", "Anti-Cytomegalovirus Drugs"], "wikidata": "Q15411004"}, "informa": {"phase": ["Phase III"], "drug_name": ["brincidofovir", "brincidofovir iv", "cidofovir prodrug iv, Chimerix", "cidofovir prodrug, Chimerix", "cidofovir prodrug, Chimerix (oral)", "cidofovir prodrug, Chimerix (topical)", "CMX-001 iv, Chimerix", "CMX-001, Chimerix", "CMX-001, Chimerix (oral)", "CMX-001, Chimerix (topical)", "CMX-021", "CMX-021 iv", "CMX-064", "CMX-064 iv", "CMX001, Chimerix", "CMX001, Chimerix (oral)", "CMX001, Chimerix (topical)", "HDP-CDV", "hexadecyloxypropyl-cidofovir", "hexadecyloxypropyl-cidofovir iv"], "PubChem CID": "CID483477", "target_name": ["E9L, smallpox virus", "UL54, cytomegalovirus"], "smiles": "CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)Cn1ccc(N)nc1=O |r|", "origin": "Chemical, synthetic", "ikey": "WXJFKKQWPMNTIM-VWLOTQADSA-N", "chemical_name": "3-(hexadecyloxy)propyl hydrogen ((S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yloxy)methylphosphonate", "informa_id": "informa_05449", "mechanism": ["DNA directed DNA polymerase inhibitor"], "target_families": ["Enzyme > Polymerase", "Enzyme > Polymerase", ""], "wikidata": "Q15411004"}, "assay": [{"ac50": 1.41e-06, "PubChem CID": "CID483477", "pubchem_label": "Brincidofovir", "assay_title": "Crypto-C. parvum HCI proliferation assay - Sterling Lab", "reframe_id": "RFM-011-191-1", "activity_type": "IC50", "ikey": "WXJFKKQWPMNTIM-VWLOTQADSA-N", "assay_id": "A00093", "chem_vendor_id": "CBR-HVAC-00831", "wikidata": "Q15411004", "chem_vendor": "WuXi"}, {"ac50": 1.38e-06, "PubChem CID": "CID483477", "pubchem_label": "Brincidofovir", "assay_title": "Crypto-C. parvum HCI proliferation assay - Bunch Grass Farm", "reframe_id": "RFM-011-191-1", "activity_type": "IC50", "ikey": "WXJFKKQWPMNTIM-VWLOTQADSA-N", "assay_id": "A00208", "chem_vendor_id": "CBR-HVAC-00831", "wikidata": "Q15411004", "chem_vendor": "WuXi"}]}}